Responding to new assay developments, BioTek Instruments, Inc. is pleased to announce that their ELx50 Filter Microplate Washer (FMW) has been recommended by Luminex Corporation for use with their xMAP® multiplex assay platform.
The compact ELx50 FMW features a syringe drive fluid-delivery system with an automated vacuum filtration solution for quick and unattended processing of 96-well filter bottom plates. Selectable vacuum levels and aspiration times provide complete filter bottom plate washing for filter pore sizes from 0.45 ìm to 1.2 ìm, and a range of fluid viscosities. Automated aspiration of liquids provides consistent wash performance and reduces the potential for operator error compared to manual methods. In addition, the modular platform allows for processing of standard microplates for traditional ELISA and cell-based assays.
According to Luminex, recovery of microspheres in the xMAP assay platform is good, even with high vacuum during aspiration and after up to six washes. In addition, blotting requirements are minimal or unnecessary, and filter microplate wells do not dry out from aspiration.
The xMAP multiplex assay platform uses microspheres that are internally dyed with fluorescent materials, coated with a test-specific substrate, and suspended in filter bottom microplate wells. When the coated substrate binds with a target molecule, two lasers excite the microsphere’s internal identifying dyes, and also any reporter dye captured during the assay. The resulting fluorescence is detected with flow cytometry.
BioTek Instruments, Inc., headquartered in Winooski, VT, is a worldwide leader in the design, manufacture, and sale of microplate instrumentation and software. BioTek instrumentation is used to accelerate the drug discovery process, to advance discoveries in genomics and proteomics, and to aid in the advancement of life science research.
Luminex Corporation develops, manufactures and markets proprietary biological testing technologies with applications throughout the life sciences industry. The Company’s xMAP® system is an open-architecture, multi-analyte technology platform that delivers fast, accurate and cost-effective bioassay results to markets as diverse as pharmaceutical drug discovery, clinical diagnostics and biomedical research, including the genomics and proteomics research markets. The Company’s xMAP technology is sold worldwide and is already in use in leading research laboratories as well as major pharmaceutical, diagnostic and biotechnology companies.
xMAP is a registered trademark of Luminex Corporation.
For further information, contact:
Jason Greene, Product Manager
BioTek Instruments, Inc.
Chere Griffin, Account Executive
Shaw & Todd Advertising and Marketing Communications
(908) 668-1106 x15